Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of…
Arena Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to etrasimod, a highly selective, once-daily, oral…
Read More...
Read More...
